Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

No conclusions about the effectiveness of Compound Jinqiancao Granules for prostatitis can be made.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Understanding patients' emotions can help oncologists improve communication and support during treatment decisions.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Patients with limited English prefer professional language interpretation in otolaryngology clinics.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

RCS-01 cell therapy is safe and improves skin gene expression.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Erlotinib can cause excessive eyelash growth.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.